BGIM
EBS icon

Brandywine Global Investment Management’s Emergent Biosolutions EBS Stock Holding History

Brandywine Global Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.61M Sell
130,310
-5,100
-4% -$54.6K 0.01% 498
2025
Q3 		$1.19M Buy
+135,410
New +$1.05M 0.01% 533

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brandywine Global Investment Management's EBS Position: Q4 2025 in Review

Brandywine Global Investment Management reduced its Emergent Biosolutions (EBS) stake by 3.8% in Q4 2025, selling an estimated $54.6K and leaving 130,310 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #498.

Brandywine Global Investment Management first reported a position in EBS in Q3 2025 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Brandywine Global Investment Management held 130,310 shares of Emergent Biosolutions worth $1.61M as of Q4 2025.
  • Brandywine Global Investment Management sold 5,100 Emergent Biosolutions shares in Q4 2025, an estimated $54.6K.
  • Emergent Biosolutions made up 0.01% of Brandywine Global Investment Management's portfolio in Q4 2025, its #498 holding.
  • Brandywine Global Investment Management first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.